Oncologist Vinay Prasad has been appointed as the new head of the FDA's Center for Biologics Evaluation and Research (CBER). Known for his controversial critiques of COVID-19 public health responses, including vaccine mandates, Prasad's appointment has sparked varied reactions. FDA Commissioner Martin Makary praised Prasad's scientific rigor and independence as essential for CBER. Previously, Prasad faced backlash for equating pandemic responses with historical totalitarianism, inviting significant critique. His appointment raises questions regarding future FDA decisions, particularly in vaccine approvals, following his vocal criticisms of past leadership.
Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER-a significant step forward.
Prasad's combative social media postings criticize mainstream medical responses during the pandemic, including vaccine mandates.
The comparison of pandemic responses to Adolf Hitler's Third Reich led to rebuke from bioethicist Arthur Caplan, deeming it ludicrous.
Prasad has accused his predecessor at CBER of being either incompetent or corrupt regarding booster vaccine approvals.
Collection
[
|
...
]